Skip Navigation



Annals of Oncology Advance Access published online on September 25, 2007
Annals of Oncology, doi:10.1093/annonc/mdm395
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
19/1/109    most recent
mdm395v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Ruano-Ravina, A.
Right arrow Articles by Barros-Dios, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ruano-Ravina, A.
Right arrow Articles by Barros-Dios, J. M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2007 European Society for Medical Oncology

Analysis of the relationship between p53 immunohistochemical expression and risk factors for lung cancer, with special emphasis on residential radon exposure

A. Ruano-Ravina1,2,*, R. Pérez-Becerra3, M. Fraga3, K. T. Kelsey4 and J. M. Barros-Dios1,5

1 Department of Preventive Medicine and Public Health, University of Santiago de Compostela, Santiago de Compostela
2 Galician Agency for Health Technology Assessment, Galician Department of Health Santiago de Compostela
3 Department of Pathological Anatomy, Santiago de Compostela Clinical University Hospital, Santiago de Compostela Spain
4 Department of Genetics and Complex Diseases, Harvard School of Public Health, Harvard University Boston, MA, USA
5 Preventive Medicine Service, Santiago de Compostela Clinical University Hospital, Santiago de Compostela Spain

* Correspondence to: Prof. A. Ruano-Ravina, Department of Preventive Medicine and Public Health, School of Medicine, C/San Francisco s/n, University of Santiago de Compostela, CP 15782 Santiago de Compostela, Spain. Tel: +34-981-581237; Fax: +34-981-572282; E-mail: mralbert{at}usc.es

Background: Indoor radon exposure has been postulated as the second risk factor of lung cancer after tobacco. The objective of this work is to analyze if there exists any effect on p53 immunohistochemical expression mainly due to radon exposure and other risk factors for lung cancer.

Patients and methods: The tumor samples of a case series of 163 lung cancer cases were analyzed to know the p53 staining. The staining was classified into four categories from no staining to intense staining (>60%). This staining was correlated with radon exposure, tobacco consumption, having worked in risk occupations for lung cancer and alcohol consumption.

Results: Only 72 samples could be analyzed for immunohistochemistry and some of these samples were sequenced from exons 4–8. No association was observed for staining intensity and radon exposure and also for tobacco and occupation. A slight association with a more intense staining was observed for high alcohol intake. In the four samples with a staining >60% that could be sequenced from exons 4 to 8, no mutation was observed in the p53 gene.

Conclusion: There is no association between radon exposure and p53 expression, indicating that maybe the effect of radon is not mediated through p53 alterations.

gene p53, immunohistochemistry, lung neoplasms, radon

Received for publication March 17, 2007. Revision received July 10, 2007. Accepted for publication July 10, 2007.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.